Search research articles
Contact Us
Filters
Showing results (111-120 of 336) with videos related to
Page
of 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2007
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris, Herbert Fritsche, Robert Mennel, et al.
Journal of the National Cancer Institute
|
March 15, 2014
Promoting quality and evidence-based care in early-stage breast cancer follow-up
N Lynn Henry, Lynn N Henry, Daniel F Hayes, et al.
Breast Cancer Research and Treatment
|
September 28, 2005
A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients
Claudine Isaacs, Rebecca Slack, Edmund Gehan, et al.
Journal of Proteome Research
|
April 22, 2008
Development and validation of sandwich ELISA microarrays with minimal assay interference
Rachel M Gonzalez, Shannon L Seurynck-Servoss, Sheila A Crowley, et al.
Clinical Chemistry
|
April 18, 2015
Validation of new cancer biomarkers: a position statement from the European group on tumor markers
Michael J Duffy, Catharine M Sturgeon, György Sölétormos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2004
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia
Vered Stearns, Andrew Coop, Baljit Singh, et al.
Breast Cancer Research : BCR
|
September 20, 2005
CYP2D6 genotype and tamoxifen response
James M Rae, Matthew P Goetz, Daniel F Hayes, et al.
Cancer
|
June 22, 2011
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms
N Lynn Henry, Mousumi Banerjee, Max Wicha, et al.
Journal of the National Cancer Institute
|
December 5, 2003
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine
Vered Stearns, Michael D Johnson, James M Rae, et al.
Clinical Breast Cancer
|
December 17, 2008
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338
Helen K Chew, William E Barlow, Kathy Albain, et al.
Page
of 34
Search research articles
Search
Showing results (111-120 of 336) with videos related to
Sort By:
Page
of 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2007
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris, Herbert Fritsche, Robert Mennel, et al.
Journal of the National Cancer Institute
|
March 15, 2014
Promoting quality and evidence-based care in early-stage breast cancer follow-up
N Lynn Henry, Lynn N Henry, Daniel F Hayes, et al.
Breast Cancer Research and Treatment
|
September 28, 2005
A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients
Claudine Isaacs, Rebecca Slack, Edmund Gehan, et al.
Journal of Proteome Research
|
April 22, 2008
Development and validation of sandwich ELISA microarrays with minimal assay interference
Rachel M Gonzalez, Shannon L Seurynck-Servoss, Sheila A Crowley, et al.
Clinical Chemistry
|
April 18, 2015
Validation of new cancer biomarkers: a position statement from the European group on tumor markers
Michael J Duffy, Catharine M Sturgeon, György Sölétormos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2004
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia
Vered Stearns, Andrew Coop, Baljit Singh, et al.
Breast Cancer Research : BCR
|
September 20, 2005
CYP2D6 genotype and tamoxifen response
James M Rae, Matthew P Goetz, Daniel F Hayes, et al.
Cancer
|
June 22, 2011
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms
N Lynn Henry, Mousumi Banerjee, Max Wicha, et al.
Journal of the National Cancer Institute
|
December 5, 2003
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine
Vered Stearns, Michael D Johnson, James M Rae, et al.
Clinical Breast Cancer
|
December 17, 2008
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338
Helen K Chew, William E Barlow, Kathy Albain, et al.
Page
of 34